Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Alnylam pharmaceuticals, inc – product pipeline review – 2012


Published on

2012 | Alnylam Pharmaceuticals, Inc – Product Pipeline Review – 2012

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Alnylam pharmaceuticals, inc – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Alnylam Pharmaceuticals, Inc – Product Pipeline Review –2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Market Direct’s pharmaceuticals report, “Alnylam Pharmaceuticals, Inc -Product Pipeline Review - 2012” provides data on the Alnylam Pharmaceuticals,Inc’s research and development focus. The report includes information on currentdevelopmental pipeline, complete with latest updates, and features on discontinuedand dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Alnylam Pharmaceuticals, Inc’s corporate website, SECfilings, investor presentations and featured press releases, both from AlnylamPharmaceuticals, Inc and industry-specific third party sources, put together byGlobal Markets Direct’s team.Scope
  2. 2. - Alnylam Pharmaceuticals, Inc - Brief Alnylam Pharmaceuticals, Inc overviewincluding business description, key information and facts, and its locations andsubsidiaries.- Review of current pipeline of Alnylam Pharmaceuticals, Inc human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:List of Tables 7List of Figures 9Alnylam Pharmaceuticals, Inc Snapshot 10Alnylam Pharmaceuticals, Inc Overview 10Key Information 10Key Facts 10Arena Pharmaceuticals, Inc. – Research and Development Overview 11Key Therapeutic Areas 11Arena Pharmaceuticals, Inc. – Pipeline Review 14Pipeline Products by Stage of Development 14Pipeline Products – Monotherapy 15Arena Pharmaceuticals, Inc. – Pipeline Products Glance 16Arena Pharmaceuticals, Inc. Clinical Stage Pipeline Products 16Phase II Products/Combination Treatment Modalities 16Phase I Products/Combination Treatment Modalities 17Arena Pharmaceuticals, Inc. – Early Stage Pipeline Products 18Pre-Clinical Products/Combination Treatment Modalities 18Discovery Products/Combination Treatment Modalities 19Arena Pharmaceuticals, Inc. – Drug Profiles 20ALN-APC Program 20Product Description 20Mechanism of Action 20R&D Progress 20ALN-HPN 21Product Description 21Mechanism of Action 21
  3. 3. R&D Progress 21ALN-HTT 22Product Description 22Mechanism of Action 22R&D Progress 22ALN-PCS 23Product Description 23Mechanism of Action 23List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview – 2012&PubId=&pagenum=1Alexion Pharmaceuticals, Inc. – Product Pipeline Review – 2012Alnylam Pharmaceuticals, Inc – Product Pipeline Review – 2012Ampio Pharmaceuticals, Inc. – Product Pipeline Review – 2012Arena Pharmaceuticals, Inc. – Product Pipeline Review – 2012ArQule, Inc. – Product Pipeline Review – 2012Baxter International Inc. – Product Pipeline Review – 2012
  4. 4. BioCryst Pharmaceuticals, Inc. – Product Pipeline Review – 2012Columbia Laboratories Inc. – Product Pipeline Review – 2012Corcept Therapeutics Incorporated – Product Pipeline Review – 2012Curis, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: